Skip to main content
Premium Trial:

Request an Annual Quote

Pharmacogenomics to Benefit from Steven Burrill s New $300M-$500M Life Sciences Venture Capital Fund

NEW YORK, Jan. 7 (GenomeWeb News) - Burrill & Company, a San Francisco-based life sciences merchant bank, is launching a $300-million to $500-million venture capital fund dedicated to biotechnology, personalized medicine, new diagnostics, and devices.

 

"We're looking at tools and technologies that will move us further and faster towards personalized and predictive medicine," Steven Burrill, CEO of the company, told GenomeWeb News today. "Biomarkers would be a real important part of that, as well as technology that will allow you to walk into a lab and get your genome sequenced."

 

According to Burrill, the new fund, called the Burrill Life Sciences Capital Fund III, will go to 20 to 25 companies worldwide at various stages of development, from seed and early stage to mezzanine levels. Each company will receive about $20 million in funding.

 

Burrill & Company currently has $500 million under management. BLSCF III is Burrill's third generation of venture funds. First generation funds, established in 1998, include a human health-care focused fund called the Burrill Biotechnology Capital Fund, the Burrill Agbio Capital Fund and the Burrill Nutraceuticals Capital Fund. Second generation funds, established in 2002, include the $211 million Burrill Life Sciences Capital fund.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.